Drug
Drug
CLASSIFICATION
ACTION
DOSAGE/ROUTE/FREQU ENCY
INDICATION
NURSING CONSIDERATION
History: Allergy to any aminoglycosides; renal or hepatic disease; preexisting hearing loss; active infection with herpes, vaccinia, varicella, fungal infections, myobacterial infections (ophthalmic preparations); myasthenia gravis; parkinsonism; infant botulism; lactation, pregnancy Physical: Site of infection; skin color, lesions; orientation, reflexes, eighth cranial nerve function; P, BP; R, adventitious sounds; bowel sounds, liver evaluation; urinalysis, BUN, serum creatinine, serum electrolytes, liver function tests, CBC
EVALUATI ON
Broad-spectrum aminoglycoside antibiotic derived from Micromonosporapurpur ea. Action is usually bacteriocidal
1.5 to 2 mg/kg loading dose, followed by 1 to 1.7 mg/kg IV or IM every 8 hours or 5 to 7 mg/kg IV q 24 hours.
Parenteral use restricted to treatment of serious infections of GI, respiratory, and urinary tracts, CNS, bone, skin, and soft tissue (including burns) when other less toxic antimicrobial agents are ineffective or are contraindicated
The patient was able to take the drug in right dosage, route and frequency without any adverse reactions.